Development of commercial propositions for Respon Therapeutics in the management of chronic skin diseases
The objective of this report is to develop and analyse the commercial proposition of “Respon Therapeutics” in the management of chronic inflammatory skin diseases. “Respon Therapeutics” is a proprietary platform precision drug-delivery system developed by Professor Dang’s Laboratory for the manageme...
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Final Year Project (FYP) |
| Lenguaje: | English |
| Publicado: |
Nanyang Technological University
2024
|
| Materias: | |
| Acceso en línea: | https://hdl.handle.net/10356/177425 |